PathoQuest Achieves CE Mark for the iDTECT™ Blood Test

iDTECT™ Blood is the first NGS-based metagenomics test to be CE-IVD marked for the clinical identification of pathogens from blood samples Click here to view French version of this release PathoQuest, a biotechnology company spun out from Institut Pasteur, today...

PathoQuest Announces Changes to Executive Leadership Team

PathoQuest today announced changes to the executive leadership team effective immediately. Jean-François Brepson is appointed by the board as President & Chief Executive Officer. This announcement follows the resignation for personal reasons of Guy-Charles de la...